[1]
|
C. Menaa, N. Kurihara and G. D. Roodman, “CFU-GM Derived Cells Form Osteoclasts at a Very High Efficiency,” Biochemical and Biophysical Research Communications, Vol. 267, No. 3, 2000, pp. 943-946. http://dx.doi.org/10.1006/bbrc.1999.2042
|
[2]
|
M. Zaidi, “Skeletal Remodeling in Health and Disease,” Nature Medicine, Vol. 13, No. 7, 2007, pp. 791-801. http://dx.doi.org/10.1038/nm1593
|
[3]
|
M. Yavropoulou and J. G. Yovos, “Osteoclastogenesis- Current Knowledge and Future Perspectives,” The Journal of Musculoskeletal and Neuronal Interactions, Vol. 8, No. 3, 2008, pp. 204-216.
|
[4]
|
O. H. Kwon, C. K. Lee, Y. I. Lee, S. G. Paik and H. J. Lee, “The Hematopoietic Transcription Factor PU.1 Regulates RANK Gene Expression in Myeloid Progenitors,” Biochemical and Biophysical Research Communications, Vol. 335, No. 2, 2005, pp. 437-446. http://dx.doi.org/10.1016/j.bbrc.2005.07.092
|
[5]
|
W. C. Dougall, M. Glaccum, K. Charrier, K. Roharbach, T. De Smedt, E. Daro, J. Smith, M. E. Tometsko, C. R. Maliszewski, A. Armstrong, V. Shen, S. Bain, D. Cosman, D. Anderson, P. J. Morrissey, J. J. Peschon and J. Schuh, “RANK Is Essential for Osteoclast and Lymph Node Development,” Genes and Development, Vol. 13, 1999, pp. 2412-2424. http://dx.doi.org/10.1101/gad.13.18.2412
|
[6]
|
H. Takayanagi, “Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling for Terminal Differentiation of Osteoclasts,” Developmental Cell, Vol. 3, No. 6, 2002, pp. 889-901. http://dx.doi.org/10.1016/S1534-5807(02)00369-6
|
[7]
|
M. Matsumoto, M. Kogawa, S. Wada, H. Takayanagi, M. Tsujimoto, S. Katayama, K. Hisatake and Y. Nogi, “Essential Role of p38 Mitogen-Activated Protein Kinase in Cathepsin K Gene Expression during Osteoclastogenes Is through Association of NFATc1 and PU.1,” Journal of Biological Chemistry, Vol. 279, No. 44, 2004, pp. 45969- 45979. http://dx.doi.org/10.1074/jbc.M408795200
|
[8]
|
Y. Kim, K. Sato, M. Asagiri, I. Morita, K. Soma and H. Takayanagi, “Contribution of NFATc1 to the Transcriptional Control of Immuno Receptor OSCAR But Not TREM-2 during Osteoclastogenesis,” Journal of Biological Chemistry, Vol. 280, No. 38, 2005, pp. 32905-32913. http://dx.doi.org/10.1074/jbc.M505820200
|
[9]
|
N. Kim, M. Takami and J. Rho, “A Novel Member of the Leukocyte Receptor Complex Regulates Osteoclast Differentiation,” Journal of Experimental Medicine, Vol. 195, No. 2, 2002, pp. 201-209.
|
[10]
|
T. Koga, “Costimulatory Signals Mediated by the ITAM Motif Cooperate with RANKL for Bone Homeostasis,” Nature, Vol. 428, No. 6984, 2004, pp. 758-763. http://dx.doi.org/10.1038/nature02444
|
[11]
|
H. Takayanagi, “Osteoimmunology: Shared Mechanisms and Crosstalk between the Immune and Bone Systems,” Nature Reviews Immunology, Vol. 7, No. 4, 2007, pp. 292-304. http://dx.doi.org/10.1038/nri2062
|
[12]
|
A. Brunet, L. B. Sweeney, J. F. Sturgill, K. F. Chua, P. L. Greer, Y. Lin, H. Tran, S. E. Ross, R. Mostoslavsky, H. Y. Cohen, L. S. Hu, H. L. Cheng, M. P. Jedrychowski, S. P. Gygi, D. A. Sinclair, F. W. Alt and M. E. Greenberg, “Stress-Dependent Regulation of FOXO Transcription Factors by the SIRT1 Deacetylase,” Science, Vol. 303, No. 5666, 2004, pp. 2011-2015. http://dx.doi.org/10.1126/science.1094637
|
[13]
|
G. Dewson, T. Kratina, H. W. Sim, H. Puthalakath, J. M. Adams, P. M. Colman and R. M. Kluck, “To Trigger Apoptosis, Bak Exposes Its BH3 Domain and Homodimerizes via BH3: Groove Interactions,” Molecular Cell, Vol. 30, No. 3, 2008, pp. 369-380. http://dx.doi.org/10.1016/j.molcel.2008.04.005
|
[14]
|
E. Gavathiotis, M. Suzuki, M. L. Davis, K. Pitter, G. H. Bird, S. G. Katz, H. C. Tu, H. Kim, E. H. Cheng, N. Tjandra and L. D. Walensky, “BAX Activation Is Initiated at a Novel Interaction Site,” Nature, Vol. 455, No. 7216, 2008, pp. 1076-1081. http://dx.doi.org/10.1038/nature07396
|
[15]
|
S. Tanaka, H. Wakeyama, T. Akiyama, K. Takahashi, H. Amano, K. I. Nakayama and K. Nakamura, “Regulation of Osteoclast Apoptosis by bcl-2 Family Protein Bim Andcaspase-3,” Advances in Experimental Medicine and Biology, Vol. 658, 2010, pp. 111-116.
|
[16]
|
H. J. Fujiki, “Two Stages of Cancer Prevention with Green Tea,” Journal of Cancer Research and Clinical Oncology, Vol. 125, No. 11, 1999, pp. 589-597. http://dx.doi.org/10.1007/s004320050321
|
[17]
|
M. Kamon, R. Zhao and K. Sakamoto, “Green Tea Polyphenol (–)-Epigallocatechingallate Suppressed the Differentiation of Murine Osteoblastic MC3T3-E1 Cell,” Cell Biology International, Vol. 34, 2010, pp. 109-116.
|
[18]
|
H. Takahashi, Y. Akatsu, N. Udagawa, T. Sasaki, A. Ymaguchi and J. M. Moseley, “Osteoblastic Cells Are Involved in Osteoclast Formation,” Endocrinology, Vol. 123, No. 5, 1988, pp. 2600-2602. http://dx.doi.org/10.1210/endo-123-5-2600
|
[19]
|
M. Matsumoto, T. Sudo, M. Maruyama, H. Osada and M. Tsujimoto, “Activation of p38 Mitogen-Activated Protein kinase Is Crucial in Osteoclastogenesis Induced by Tumor Necrosis Factor,” FEBBS Letter, Vol. 486, No. 1, 2000, pp. 23-28. http://dx.doi.org/10.1016/S0014-5793(00)02231-6
|
[20]
|
J. K. Chang, Y. L. Hsu, I. C. Teng and P. L. Kuo, “Piceatannol Stimulates Osteoblast Differentiation that May Be Mediated by Increased Bone Morphogenetic Protein-2 Production,” European Journal of Pharmacology, Vol. 551, No. 1-3, 2006, pp. 1-9. http://dx.doi.org/10.1016/j.ejphar.2006.08.073
|
[21]
|
K. Kodaria, M. Imada, M. Goto, A. Tomoyasu, T. Fukuda and R. Kamijo, “Purification and Identification of a BMP- Like Factor from Bovine Serum,” Biochemical and Biophysical Research Communications, Vol. 345, No. 3, 2006, pp. 1224-1231. http://dx.doi.org/10.1016/j.bbrc.2006.05.045
|
[22]
|
P. Chomczynski and N. Sacchi, “Single-Step Method of RNA Isolationby Acid Guanidiniumthiocyanate-phenol- Chloroform Extraction,” Analytical Biochemistry, Vol. 162, 1987, pp. 156-159. http://dx.doi.org/10.1016/0003-2697(87)90021-2
|
[23]
|
N. Ishida, K. Hayashi, M. Hoshijima, T. Ogawa, S. Koga and Y. Miyatake, “Large Scale Gene Expression Analysis of Osteoclastogenesis in Vitro and Elucidation of NFAT2 as a Key Regulator,” Journal of Biological Chemistry, Vol. 277, No. 43, 2002, pp. 41147-41156. http://dx.doi.org/10.1074/jbc.M205063200
|
[24]
|
H. Kodama, Y. Amagai and S. Sudo, “Establishment of a Clonal Osteogenic Cell Line from Newborn Mouse Calvaria,” Japanese Journal of Oral Biology, Vol. 23, 1981, pp. 899-901. http://dx.doi.org/10.2330/joralbiosci1965.23.899
|
[25]
|
T. Katagiri and N. Takahashi, “Regulatory Mechanisms of Osteoblast and Osteoclast Differentiation,” Oral Diseases, Vol. 8, No. 3, 2002, pp. 147-159. http://dx.doi.org/10.1034/j.1601-0825.2002.01829.x
|
[26]
|
W. J. Boyle, W. S. Simonet and D. L. Lacey, “Osteoclast Differentiation and Activation,” Nature, Vol. 423, No, 6937, 2003, pp. 337-342. http://dx.doi.org/10.1038/nature01658
|
[27]
|
Y. Y. Kong, H. Yshida, I. Sarosi, H. L. Tan, E. Timms, C. Capparelli, S. Morony, A. J. Oliveira-dos-Santos, G. Van, A. Itie, W. Khoo, A. Wakeham, C. R. Dunstan, D. L. Lacey, T. W. Mak, W. J. Boyle and J. M. Penninger, “OPGL Is a Key Regulator of Osteoclastogenesis, Lymphocyte Development and Lymph-Node Organogenesis,” Nature, Vol. 397, No. 6717, 1999, pp. 315-323. http://dx.doi.org/10.1038/16852
|
[28]
|
D. J. Eric, P. Lan, J. B. J. Charles, E. Kelly, E. C. Ann, J. W. Jennifer, P. Anna, G. Rajaram and M. Kim, “Bone Morphogenic Protein 2 Directly Enhances Differentiation of Murine Osteoclast Precursors,” Journal of Cellular Biochemistry, Vol. 109, No. 4, 2010, pp. 672-682.
|
[29]
|
I. Song, J. H. Kim, K. Kim, H. M. Jin, B. U. Youn and N. Kim, “Regulatory Mechanism of NFATc1 in RANKL- Induced Osteoclast Activation,” FEBS Letter, Vol. 583, No. 14, 2009, pp. 2435-2440. http://dx.doi.org/10.1016/j.febslet.2009.06.047
|
[30]
|
Y. C. Shang, Z. Z. Chong, J. Hou and K. Maiese, “Foxo3a Governs Early Microglial Proliferation and Employs Mitochondrial Depolarization with Caspase 3, 8, and 9 Cleavage during Oxidant Induced Apoptosis,” Current Neurovascular Research, Vol. 6, No. 4, 2009, pp. 223- 238. http://dx.doi.org/10.2174/156720209789630302
|
[31]
|
O. Johnell, B. Gullberg, J. A. Kanis, E. Allander, L. Elffors, J. Dequeker, G. Dilsen, C. Gennari, V. A. Lopes and G. Lyritis, “Risk Factors for Hip Fracture in European Women: The MEDOS Study,” Journal of Bone and Mineral Research, Vol. 10, No. 11, 1995, pp. 1802-1815. http://dx.doi.org/10.1002/jbmr.5650101125
|
[32]
|
V. M. Hegarty, H. M. May and K. T. Khaw, “Tea Drinking and Bone Mineral Density in Older Women,” The American Journal of Clinical Nutrition, Vol. 71, No. 4, 2000, pp. 1003-1007.
|
[33]
|
J. H. Yun, C. S. Kim, K. S. Cho, J. K. Chai, C. K. Kim and S. H. Choi, “(–)-Epigallocatechin Gallate Induces Apoptosis, via Caspase Activation, in Osteoclasts Differentiated from RAW246.7 Cells,” Journal of Periodontal Research, Vol. 42, 2007, pp. 212-218. http://dx.doi.org/10.1111/j.1600-0765.2006.00935.x
|
[34]
|
A. C. Bharti, Y. Takada and B. B. Aggarwal, “Curcumin (Diferuloylmethane) Inhibits Receptor Activator of NF- kappa B Ligand-Induced NF-Kappa B Activation in Osteoclast Precursors and Suppresses Osteoclastogenesis,” Journal of Immunology, Vol. 172, No. 10, 2004, pp. 5940- 5947.
|
[35]
|
P. Boissy, T. L. Andersen, B. M. Abdallah, M. Kassem, T. Plesner and J. M. Delaisse, “Resveratrol Inhibits Myeloma Cells Growth, Prevents Osteoclast Formation, and Promotes Osteoblast Differentiation,” Cancer Research, Vol. 65, No. 21, 2005, pp. 9943-9952. http://dx.doi.org/10.1158/0008-5472.CAN-05-0651
|
[36]
|
R. Iwasaki, K. Ito, T. Ishida, M. Hamanoue, S. Adachi, T. Watanabe and Y. Sato, “Catechin, Green Tea Component, Causes Caspase-Independent Necrosis-Like Cell Death in Chronic Myelogenous Leukemia,” Cancer Science, Vol. 100, No. 2, 2009, pp. 349-356. http://dx.doi.org/10.1111/j.1349-7006.2008.01046.x
|
[37]
|
U. Ullmann, J. Haller, J. P. Decourt, N. Girault, J. Girault and A. S. Richard-Caudron, “A Single Ascending Dose Study of Epigallocatechingallate in Healthy Volunteers,” Journal of International Medical Research, Vol. 31, No. 2, 2003, pp. 88-101. http://dx.doi.org/10.1177/147323000303100205
|